Naomi Campbell opens Breakthrough Breast Cancer research unit, UK

Naomi Campbell opens Breakthrough Breast Cancer research unit which aims to find treatments for aggressive type of breast cancer – Supermodel Naomi Campbell opened Breakthrough Breast Cancer’s new London research unit dedicated to finding treatments for an aggressive type of breast cancer.

SPOT-Light HER2 CISH kit approved for breast cancer patients

The U.S. Food and Drug Administration (FDA) approves new genetic test for patients with breast cancer. – SPOT-Light HER2 CISH kit – a novel genetic test for determining whether patients with breast cancer are good candidates for treatment with the drug Herceptin (trastuzumab) has been approved by the U.S. Food and Drug Administration.

Breast cancer sufferers demand answers from PHARMAC, New Zealand

Herceptin Heroines are back in the High Court today to continue their case against drug funding agency PHARMAC, New Zealand. – 8 cancer survivors are in the New Zealand High Court to fight their case against drug funding agency PHARMAC. The women are challenging PHARMAC’s decision not to fund 12 months of Herceptin treatment for NZ women with HER2 positive breast cancer.

Black women get breast cancer two decades earlier than white women

Black British women in UK are diagnosed with breast cancer 21 years younger than white British women. – Black British women in Hackney, East London, are diagnosed with breast cancer 21 years younger than white British women, according to a Cancer Research UK study published online in the British Journal of Cancer.

Health Newstrack